nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—PIK3C2B—Signaling events mediated by Stem cell factor receptor (c-Kit)—MITF—vascular cancer	0.12	0.12	CbGpPWpGaD
Lapatinib—PIK3C2B—Signaling Pathways in Glioblastoma—TSC2—vascular cancer	0.0384	0.0384	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	0.0278	0.0278	CbGpPWpGaD
Lapatinib—TAP1—Direct p53 effectors—TSC2—vascular cancer	0.0271	0.0271	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	0.0269	0.0269	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—CD34—vascular cancer	0.0194	0.0194	CbGpPWpGaD
Lapatinib—ERBB2—Validated targets of C-MYC transcriptional repression—TSC2—vascular cancer	0.0193	0.0193	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways in Glioblastoma—TSC2—vascular cancer	0.0156	0.0156	CbGpPWpGaD
Lapatinib—ERBB2—Constitutive PI3K/AKT Signaling in Cancer—TSC2—vascular cancer	0.015	0.015	CbGpPWpGaD
Lapatinib—ERBB4—Constitutive PI3K/AKT Signaling in Cancer—TSC2—vascular cancer	0.0148	0.0148	CbGpPWpGaD
Lapatinib—ERBB2—PI-3K cascade—TSC2—vascular cancer	0.0135	0.0135	CbGpPWpGaD
Lapatinib—ERBB4—PI-3K cascade—TSC2—vascular cancer	0.0133	0.0133	CbGpPWpGaD
Lapatinib—ERBB2—PI3K/AKT activation—TSC2—vascular cancer	0.0132	0.0132	CbGpPWpGaD
Lapatinib—ERBB2—GAB1 signalosome—TSC2—vascular cancer	0.0131	0.0131	CbGpPWpGaD
Lapatinib—ERBB4—PI3K/AKT activation—TSC2—vascular cancer	0.013	0.013	CbGpPWpGaD
Lapatinib—ERBB4—GAB1 signalosome—TSC2—vascular cancer	0.0129	0.0129	CbGpPWpGaD
Lapatinib—ERBB2—Role of LAT2/NTAL/LAB on calcium mobilization—TSC2—vascular cancer	0.0128	0.0128	CbGpPWpGaD
Lapatinib—ERBB4—Role of LAT2/NTAL/LAB on calcium mobilization—TSC2—vascular cancer	0.0126	0.0126	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—WWTR1—vascular cancer	0.0124	0.0124	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—WWTR1—vascular cancer	0.012	0.012	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CD34—vascular cancer	0.0117	0.0117	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by SCF-KIT—TSC2—vascular cancer	0.0101	0.0101	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by SCF-KIT—TSC2—vascular cancer	0.00998	0.00998	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.00969	0.00969	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.00954	0.00954	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB4—TSC2—vascular cancer	0.00954	0.00954	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB4—TSC2—vascular cancer	0.00939	0.00939	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signal transduction—TSC2—vascular cancer	0.00911	0.00911	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR—TSC2—vascular cancer	0.00906	0.00906	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB2—TSC2—vascular cancer	0.00902	0.00902	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 signaling—TSC2—vascular cancer	0.00897	0.00897	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signal transduction—TSC2—vascular cancer	0.00897	0.00897	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR—TSC2—vascular cancer	0.00893	0.00893	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB2—TSC2—vascular cancer	0.00888	0.00888	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.00884	0.00884	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 signaling—TSC2—vascular cancer	0.00884	0.00884	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.00871	0.00871	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.00844	0.00844	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—TSC2—vascular cancer	0.00844	0.00844	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR in disease—TSC2—vascular cancer	0.00844	0.00844	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—TSC2—vascular cancer	0.00838	0.00838	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR—TSC2—vascular cancer	0.00837	0.00837	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.00832	0.00832	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—TSC2—vascular cancer	0.00832	0.00832	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR in disease—TSC2—vascular cancer	0.00832	0.00832	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.00829	0.00829	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—TSC2—vascular cancer	0.00826	0.00826	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—TSC2—vascular cancer	0.00824	0.00824	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.00817	0.00817	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—TSC2—vascular cancer	0.00813	0.00813	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—TSC2—vascular cancer	0.00781	0.00781	CbGpPWpGaD
Lapatinib—ERBB4—B Cell Activation—TSC2—vascular cancer	0.0077	0.0077	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—TSC2—vascular cancer	0.00755	0.00755	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.00748	0.00748	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.00737	0.00737	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD34—vascular cancer	0.00727	0.00727	CbGpPWpGaD
Lapatinib—EGFR—Constitutive PI3K/AKT Signaling in Cancer—TSC2—vascular cancer	0.00727	0.00727	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD34—vascular cancer	0.00716	0.00716	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—HBA1—vascular cancer	0.00694	0.00694	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—HBA1—vascular cancer	0.0067	0.0067	CbGpPWpGaD
Lapatinib—EGFR—PI-3K cascade—TSC2—vascular cancer	0.00655	0.00655	CbGpPWpGaD
Lapatinib—EGFR—PI3K/AKT activation—TSC2—vascular cancer	0.00639	0.00639	CbGpPWpGaD
Lapatinib—EGFR—GAB1 signalosome—TSC2—vascular cancer	0.00634	0.00634	CbGpPWpGaD
Lapatinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—TSC2—vascular cancer	0.0062	0.0062	CbGpPWpGaD
Lapatinib—ERBB2—Disease—WWTR1—vascular cancer	0.00603	0.00603	CbGpPWpGaD
Lapatinib—ERBB4—Disease—WWTR1—vascular cancer	0.00594	0.00594	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—TSC2—vascular cancer	0.00575	0.00575	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—TSC2—vascular cancer	0.00567	0.00567	CbGpPWpGaD
Lapatinib—TAP1—Immune System—TSC2—vascular cancer	0.00508	0.00508	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TSC2—vascular cancer	0.00492	0.00492	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—TSC2—vascular cancer	0.0049	0.0049	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.00468	0.00468	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TSC2—vascular cancer	0.00463	0.00463	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—TSC2—vascular cancer	0.00461	0.00461	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD34—vascular cancer	0.00441	0.00441	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—TSC2—vascular cancer	0.0044	0.0044	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—TSC2—vascular cancer	0.00438	0.00438	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—TSC2—vascular cancer	0.00436	0.00436	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD34—vascular cancer	0.00435	0.00435	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—TSC2—vascular cancer	0.00434	0.00434	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.00428	0.00428	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—WWTR1—vascular cancer	0.00422	0.00422	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—WWTR1—vascular cancer	0.00416	0.00416	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—TSC2—vascular cancer	0.00408	0.00408	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.00408	0.00408	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—TSC2—vascular cancer	0.00408	0.00408	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—TSC2—vascular cancer	0.00404	0.00404	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.00401	0.00401	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—TSC2—vascular cancer	0.00399	0.00399	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—TSC2—vascular cancer	0.00378	0.00378	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.00361	0.00361	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD34—vascular cancer	0.00352	0.00352	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—TSC2—vascular cancer	0.00328	0.00328	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—TSC2—vascular cancer	0.00323	0.00323	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	0.00318	0.00318	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—TSC2—vascular cancer	0.00315	0.00315	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—TSC2—vascular cancer	0.0031	0.0031	CbGpPWpGaD
Lapatinib—EGFR—Disease—WWTR1—vascular cancer	0.00291	0.00291	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	0.00283	0.00283	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—TSC2—vascular cancer	0.00278	0.00278	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD34—vascular cancer	0.00213	0.00213	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—WWTR1—vascular cancer	0.00204	0.00204	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—TSC2—vascular cancer	0.00191	0.00191	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—TSC2—vascular cancer	0.00188	0.00188	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TSC2—vascular cancer	0.00176	0.00176	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TSC2—vascular cancer	0.00174	0.00174	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—WWTR1—vascular cancer	0.00163	0.00163	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—TSC2—vascular cancer	0.00159	0.00159	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—TSC2—vascular cancer	0.00152	0.00152	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—WWTR1—vascular cancer	0.00141	0.00141	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—WWTR1—vascular cancer	0.00126	0.00126	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TSC2—vascular cancer	0.00124	0.00124	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—WWTR1—vascular cancer	0.00123	0.00123	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TSC2—vascular cancer	0.00122	0.00122	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TSC2—vascular cancer	0.000924	0.000924	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—HBA1—vascular cancer	0.000914	0.000914	CbGpPWpGaD
Lapatinib—EGFR—Disease—TSC2—vascular cancer	0.000853	0.000853	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—HBA1—vascular cancer	0.000792	0.000792	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—WWTR1—vascular cancer	0.000759	0.000759	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HBA1—vascular cancer	0.000707	0.000707	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HBA1—vascular cancer	0.00069	0.00069	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TSC2—vascular cancer	0.000597	0.000597	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HBA1—vascular cancer	0.000425	0.000425	CbGpPWpGaD
